Fostamatinib inhibits B-cell receptor signaling, cellular activation and tumor proliferation in patients with relapsed and refractory chronic lymphocytic leukemia.

ABSTRACT:

SUBMITTER: Herman SE 

PROVIDER: S-EPMC3920486 | biostudies-literature | 2013 Aug

REPOSITORIES: biostudies-literature